CNBC January 17, 2025
Annika Kim Constantino

Key Points

– The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare.

– It kicks off the second phase of a landmark provision in the Inflation Reduction Act that aims to make costly medications more affordable for seniors.

– At the top of the list is Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product since they all share the same active ingredient, semaglutide.

The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off the second phase of a landmark process that aims to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
Podcast: The Politics of Alternative Payment Models
Expanding Home- And Community-Based Services For Dually Eligible Adults With Behavioral Health Needs
Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims
APG Report Calls for Major Reforms to Medicare, Medicare Advantage
AHIP Medicare, Medicaid, and Duals Conference Wrap Up

Share This Article